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Immune responses at the intestinal mucosa must allow for host protection whilst simul-
taneously avoiding inappropriate inflammation. Although much work has focused on the
innate immune functionality of hematopoietic immune cells, non-hematopoietic cell pop-
ulations – including epithelial and stromal cells – are now recognized as playing a key role
in innate defense at this site. In this study we examined the innate immune capacity of
primary human intestinal stromal cells (iSCs). CD90+ iSCs isolated from human colonic
mucosa expressed a wide array of innate immune receptors and functionally responded
to stimulation with bacterial ligands. iSCs also sensed infection with live Salmonella
typhimurium, rapidly expressing IL-1 family cytokines via a RIPK2/p38MAPK-dependent
signaling process. In addition to responding to innate immune triggers, primary iSCs exhib-
ited a capacity for bacterial uptake, phagocytosis, and antigen processing, although to a
lesser extent than professional APCs.Thus CD90+ iSCs represent an abundant population
of “non-professional” innate immune effector cells of the human colonic mucosa and likely
play an important adjunctive role in host defense and immune regulation at this site.
Keywords: stromal cells, mucosal immunology, innate immunity, intestinal homeostasis
INTRODUCTION
Emerging data suggests that non-hematopoietic stromal cells of
the intestine exhibit a wider array of immunological functions
than has been hitherto attributed to them. This includes the
production of and response to cytokines, functional interactions
with hematopoietic immune cells, the regulation of immune cell
localization, and cell-intrinsic innate immune functions (1, 2).
As data from both human (3) and murine (4) systems suggested
that intestinal stromal cells (iSCs) express functional PRR path-
ways, we sought to better define the contribution of iSCs to the
innate immune mechanisms operating in the human gut. Here
we extend the characterization of primary stromal cells isolated
from the human colonic mucosa, focusing on their ability to con-
tribute to cell-intrinsic innate immune responses to an invasive
mucosal pathogen. We confirm previous observations that human
iSCs express Toll-like receptors (TLRs), and the NOD-like recep-
tor (NLR) NOD2 at the mRNA level, and reveal that primary
iSCs also express multiple other members of the NLR family of
PRRs. We further show that human iSCs express detectable pro-
tein levels of NOD2 and can respond to the bacterial component
muramyl dipeptide (MDP) at a functional level. Similar to obser-
vations in other cell types including myeloid dendritic cells (DCs)
and a macrophage cell line (5, 6), NOD2 triggering synergizes
with TLR2 stimulation to increase the magnitude of the tran-
scriptional response to isolated bacterial components. We show
that the expression of multiple IL-1 family member cytokines is
regulated by PRR triggering in primary iSCs, with a particularly
strong response to flagellin. Consistent with this, iSCs internal-
ize and respond rapidly to in vitro infection with the flagellated
bacterium Salmonella typhimurium, increasing their expression of
IL-1β and IL-33 at both the mRNA and protein level, with this
sensing dependent on RIPK2/p38MAPK signaling. In addition to
these potent cell-intrinsic innate sensing responses, primary iSCs
had some phagocytic and antigen-processing potential, although
this was limited when compared to professional APCs. Thus we
identify CD90+ stromal cells as“non-professional”innate immune
effector cells of the human colonic mucosa.
MATERIALS AND METHODS
INTESTINAL TISSUE PREPARATION
Human colonic tissue specimens from macroscopically healthy
areas of colon were collected from colorectal cancer patients
undergoing surgery. All patients were recruited from the Trans-
lational Gastroenterology Unit and the colorectal surgery depart-
ment at the John Radcliffe Hospital, Oxford. Ethical approval
was obtained from the Oxfordshire Research Ethics Committee
(reference number 11/YH/0020), and all study participants gave
informed written consent. Colonic tissue was collagenase-digested
and processed as previously described (7), and cells from the 30–
40% Percoll gradient interface used for subsequent stromal cell
staining and culture.
INTESTINAL STROMAL CELL CULTURE
Cells were isolated from Percoll gradients and washed in PBS
containing 2% Bovine Serum Albumin (BSA). Cells were resus-
pended at 1× 106 cells/ml in complete DMEM (cDMEM) con-
taining 10% FCS,l-glutamine,10,000 U/ml Penicillin and Strepto-
mycin, 0.025µg/ml Amphotericin B, 10µg/ml Ciprofloxacin and
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40µg/ml Gentamycin (Sigma Aldrich, UK). Cells were initially
plated in six well tissue culture plates (5× 106 cells/well) or T25
culture flasks (15× 106 cells/flask). After 48–72 h, non-adherent
cells were removed by vigorous washing and media replaced with
fresh cDMEM. Cultures were monitored for the appearance of
highly adherent stromal cells with typical fibroblastic morphol-
ogy. When confluent, stromal cells were harvested using 0.1%
Trypsin-EDTA (Sigma Aldrich) and split at ratios of 1:3–1:5. Stro-
mal cultures were expanded in T75 flasks and all experiments were
performed using stromal cells between culture passages 3–8.
PRR STIMULATIONS AND BACTERIAL INFECTIONS
For stromal cell PRR stimulations, 50,000 iSCs/well were plated
in flat-bottomed 96 well plates. After 24 h, media was changed
and cells were stimulated with combinations of the following PRR
ligands: 1µg/ml PAM3CSK4, 10µg/ml MDP, 100 pg/ml Flagellin
(Invivogen, USA). At 24 h post-stimulation, cells were lysed for
subsequent RNA analysis. For bacterial infections, GFP – Salmo-
nella enterica typhimurium strain 12023 (kind gift from David
Holden) was grown to logarithmic phase (OD less than 0.5) in
LB containing ampicillin at 37°C. Infections were performed on
50,000 stromal cells/well in cDMEM without antibiotics at a mul-
tiplicity of infection (MOI) of 10 using live bacteria or bacteria
killed by heating to 65°C for 60 min. For short-term infection
experiments, cells were lysed for RNA extraction at 60 and 120 min
post-infection. For 24-h infection experiments, 10µg/ml Gen-
tamycin was added to all cultures at 4 h post-infection to prevent
bacterial overgrowth, and cell supernatants harvested at 24 h post-
infection. Proteins were quantified in cell culture supernatants
using DuoSet ELISA kits according to manufacturers instructions
(R&D Systems, UK). Where indicated, RIPK2/p38MAPK signaling
was inhibited using 10µM SB203580 (in DMSO – Sigma Aldrich),
and control cells were treated with DMSO alone.
MONOCYTE ISOLATION AND DENDRITIC CELL GENERATION
CD14+Monocytes were purified from peripheral blood mononu-
clear cells of healthy donors using CD14 MACS beads (Miltenyi
Biotec, Germany) as previously described (8). For transcrip-
tional profiling, monocytes were immediately washed, lysed in
RLT buffer (Qiagen) containing 1% β-Mercaptoethanol (Sigma
Aldrich) and frozen for subsequent RNA extraction (RNeasy Mini
Kit, Qiagen). To generate DCs, CD14+ monocytes were cultured
for 5 days in DMEM containing 10% FCS in the presence of recom-
binant human GM-CSF and IL-4 (PeproTech, UK), as previously
described (8).
FLOW CYTOMETRY
To assess surface protein expression by flow cytometry, cells iso-
lated directly ex vivo or cells cultured in vitro were washed in PBS
2% BSA, and labeled for 30 min on ice with eFluor780 viability
stain (eBioscience, San Diego, CA, USA) and anti-human mon-
oclonal antibodies against EpCAM (Clone 9C4), CD45 (Clone
HI30), and CD90 (Clone 5E10, PerCP-Cy5.5 – all BioLegend,
San Diego, CA, USA) for stromal cells, or eFluor780 viability
stain and anti-CD11c (Clone 3.9 – eBioscience) for DCs. Cells
were washed twice in PBS/BSA and fixed in BD Cytofix solu-
tion. For assessment of intracellular expression of NOD2, stromal
cells were surface stained as before, fixed and permeablized using
BD Cytofix/Cytoperm. Cells were subsequently stained for 30 min
on ice with anti-human NOD2 (Clone 2D9 – Cayman Chemical,
USA) or appropriate isotype control. Cells were washed twice with
BD Perm buffer and labeled for 30 min on ice with AlexaFluor647-
conjugated anti-mouse IgG (Life Technologies, UK) followed by
one wash in BD Perm buffer and a final wash in PBS/BSA. Samples
were acquired using a BD LSRII and data analysis performed using
FlowJo Software (Treestar, USA).
STROMAL CELL PHOSFLOW™
Intestinal stromal cells were labeled for 30 min on ice with
eFluor780 and anti-human CD90 as previously described. After
washing iSCs were plated in 150µl cDMEM in 96 well plates at
100,000 stromal cells/well and rested at 37°C for 60 min. Cells were
subsequently stimulated in sequence with 10µg/ml MDP for var-
ious time periods, or remained unstimulated. After 60 min, cells
from each stimulation condition were fixed simultaneously for
15 min at 37°C with an equal volume of pre-warmed BD Cytofix
buffer. Cells were transferred to v-bottomed 96 well plates and
subsequently washed in chilled PBS/BSA. Cells were permeablized
using BD Phosflow Perm Buffer IV for 30 min at room temperature
in the dark. Cells were washed twice in PBS/BSA and subsequently
labeled with anti-human Phospho-RIP2 (Ser 176 – Cell Signaling
Technology, USA) or appropriate rabbit isotype control in 50µl
PBS/BSA for 60 min at room temperature. Cells were washed and
subsequently labeled with AlexaFluor647-conjugated anti-rabbit
IgG (Cell Signaling Technology) for 30 min on ice and washed
twice in PBS/BSA. Samples were acquired using a BD LSRII and
data analysis performed using FlowJo Software (Treestar, USA)
DETERMINING BACTERIAL UPTAKE BY FLUORESCENCE AND
CONFOCAL MICROSCOPY
Myeloid dendritic cells (mDC) and iSC were seeded at 1× 105 cells
per well onto eight-well poly-d-lysine-coated Tissue Culture Slides
(BD Biosciences). Cells were allowed to adhere for 2 h before addi-
tion of GFP-Salmonella typhimurium for a further 2 h (MOI= 30).
Following this incubation, cells were washed with PBS and fixed
in 4% paraformaldehyde for 10 min at RT. Cells were then per-
meabilized with 0.1% (vol/vol) Triton X-100 in PBS. Cover slips
were mounted using Vectashield Mounting Medium with DAPI
(Vector Laboratories). A Zeiss Qimaging Retiga 2000R was used
for immunofluorescence microscopy. For confocal microscopy,
iSCs were seeded at 0.5× 105 cells per well onto eight-well poly-
d-lysine-coated PCA Slides (Sarstedt Ltd.). Cells were allowed
to adhere overnight before addition of GFP-Salmonella enterica
typhimurium for 4 h (MOI= 100). Following this incubation, cells
were washed with PBS and fixed in 4% paraformaldehyde for
10 min at RT. Cells were then permeabilized with 0.1% (vol/vol)
Triton X-100 in PBS and incubated with AlexaFluor647-conjugated
anti-human Vimentin XP® Monoclonal Antibody (Cell Signal-
ing Technology) in PBS-1% BSA for 30 min at RT. After staining,
cover slips were mounted using Vectashield Mounting Medium
with DAPI (Vector Laboratories). Images were acquired using a
Zeiss 780 inverted confocal microscope with an Objective Plan-
Apochromat 63×/1.40 Oil DIC. During acquisition a pinhole size
of 0.9µm was used.
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qRT-PCR
For transcriptional analysis cells were lysed in RLT buffer (Qia-
gen) containing 1% β-Mercaptoethanol (Sigma Aldrich). Sam-
ples were homogenized using QIAshredder columns and RNA
extracted using RNAeasy spin technology, according to manufac-
turers instructions (Qiagen). cDNA was synthesized from isolated
RNA using a High Capacity cDNA Reverse Transcription Kit,
according to manufacturers instructions (Life Technologies, USA).
cDNA was used for qRT-PCR reactions with buffers and specific
primer-probe sets from the TaqMan system (Life Technologies).
In all cases GAPDH was used as an endogenous reference gene,
and changes in expression levels calculated using either 2∧−∆Ct
to give levels of expression as arbitrary units (AU) relative to
GAPDH or 2∧ − ∆∆Ct to give the fold increase in expression
in experimental vs. control (unstimulated) conditions.
ANTIGEN PROCESSING AND PHAGOCYTOSIS ASSAYS
For antigen processing and phagocytosis assays, Day 5 mDCs or
cultured iSCs were plated at 100,000 cells/well in 24 well plates
and pulsed with 100µg/ml DQ-OVA (Invitrogen) or Phagocyto-
sis assay reagent (Cayman Chemicals) for 4 h. Cells were pulsed
at either 37°C or on ice. Subsequently, cells were stained for
flow cytometry as previously described. Antigen processing/bead
uptake was assessed as the fold increase in FITC-expression by cells
at 37°C over background processing/uptake levels determined in
CD11c+ mDCs or CD90+ iSCs after pulsing with the respective
reagents on ice. Flow cytometry data was acquired and analyzed
as previously described.
STATISTICAL ANALYSIS
All analysis was performed in GraphPad Prism (v5.0d). For com-
parisons between two groups an unpaired Student’s t -test was
used; for comparisons across multiple groups either a one-way
ANOVA, followed by a Bonferroni post-test, or a Kruskal–Wallis,
with Dunn’s post-test, were performed. p values of less than 0.05
were considered significant.
RESULTS
CD90+ COLONIC STROMAL CELLS EXPRESS DIVERSE PRRs AND
FUNCTIONAL NOD2
We first sought to characterize PRR expression by stromal cells of
the human colonic mucosa. Collagenase-digested colonic mucosal
tissue contained an abundant population of viable, CD45− non-
hematopoietic cells (Figure 1A). When assessed by flow cytometry
directly ex vivo, this population comprised EpCAM+ epithelial
cells, CD90+ stromal cells, and a group of EpCAM−CD90− non-
hematopoietic cells, likely containing populations of endothelial
and other stromal cell types (2). After 10 days of culture, most cells
were negative for both CD45 and EpCAM, but expressed CD90
and had a fibroblastic morphology, similar to the features of iSCs
previously characterized in colonic tissues of mice and humans (9,
10) (Figure 1A). Upon continued culture the cells retained CD90
expression throughout multiple culture passages in vitro (data not
shown). Thus CD90+ stromal cells represent a culturable popula-
tion of primary non-hematopoietic cells in the human colon. We
next compared levels of PRR expression in iSCs to a prototypic
“professional” innate immune cell population. CD14+ monocytes
were purified from peripheral blood of healthy donors. The levels
of PRR mRNAs in monocytes and iSCs were quantified by qPCR
as AU relative to the housekeeping gene GAPDH. Consistent with
previous reports from human and murine systems (3, 4), iSCs
expressed a wide array of PRRs, although in general expression
levels were lower than that in blood monocytes (Figures 1B–E).
Uniquely amongst the PRRs examined, the expression of NOD1
in iSCs was equivalent to that in CD14+monocytes, at 1.41± 0.45
vs. 1.35± 0.87 AU (p= ns), respectively (Figure 1B). In contrast
NOD2 was expressed at significantly lower levels in iSCs than
monocytes (0.06± 0.04 vs. 4.80± 1.26 AU, p< 0.001) and TLR4
expression was similarly lower in iSCs (1.25± 0.82 vs. 3.61± 1.43,
p< 0.01) (Figure 1B). iSCs also expressed TLR5, albeit at lower
levels than monocytes (Figure 1B). iSCs additionally expressed
mRNA for the inflammasome-linked sensors NLRP1 and NLRP3
(Figure 1C), although expression was significantly lower com-
pared to monocytes. Although previous data has indicated that
murine stromal cells express abundant levels of NLRP6 (11),
expression of NLRP6 mRNA in human iSCs was very low and
not detectable in cells isolated from all patients (data not shown).
Unlike monocytes, iSCs did not express detectable levels of the
inflammasome sensor NLRC4 (Figure 1D) together indicating
that iSCs express specific members of PRR families, and not low
levels of all receptors. As inflammasome assembly and function
is critically dependent on the adapter protein Asc (PYCARD in
humans) (12) we sought to determine whether PYCARD expres-
sion was detectable in iSCs. Similar to the NLR inflammasome
sensors themselves, iSCs did express PYCARD mRNA, but at sig-
nificantly lower levels than monocytes (Figure 1E). Interestingly
the NLR co-receptor NAIP was consistently expressed in iSCs,
although also at significantly reduced levels when compared to
monocytes (0.66± 0.38 vs. 20.62± 11.98 AU, p< 0.001).
Given that mRNA expression of NOD2 was so much lower than
in monocytes, we next sought to determine whether iSCs expressed
detectable protein levels of NOD2 and whether this expression
allowed them to respond to the prototypic NOD2 ligand, Muramyl
dipeptide (MDP). When assessed by intracellular flow cytome-
try we found that viable cultured CD90+ stromal cells expressed
NOD2 at the protein level (Figure 1F). This was functional, since
upon stimulation with MDP in vitro, expression of phosphorylated
RIPK2 by iSCs increased in a time-dependent fashion, with lev-
els up to threefold higher after 60 min of stimulation with MDP
(Figure 1G). Taken together, the expression profiling and func-
tional stimulation experiments suggest that iSCs are equipped with
multiple PRR-linked innate sensing mechanisms and can respond
to a bacterial PRR ligand that activates NOD2.
BACTERIAL LIGANDS REGULATE IL-1 FAMILY MEMBER CYTOKINE
EXPRESSION IN iSCs
We next determined the extent to which isolated bacterial com-
ponents could regulate cytokine responses at the transcriptional
level in iSCs. As the IL-1 family is involved in mucosal home-
ostasis we focused on IL-1 family cytokines. We stimulated pri-
mary CD90+ iSCs in vitro with bacterially derived PRR ligands
and determined the regulation of cytokine mRNA expression
(Figure 2). As bacterial triggering through NOD2 synergizes with
TLR2 signaling for maximal functional responses in myeloid cells
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FIGURE 1 | CD90+ colonic stromal cells express diverse PRRs and
functional NOD2. (A) Shows representative flow cytometric staining of
collagenase-digested colonic tissue ex vivo and cultured stromal cells after
10 days in culture, revealing iSCs as viable, CD45−EpCAM−CD90+ cells; and a
representative image of day 10 cultured stromal cells obtained by light
microscopy. (B–E) Show quantification of the expression of the indicted
genes in monocytes and cultured iSCs by qRT-PCR, expressed as arbitrary
units (AU) relative to GAPDH. (F) Shows quantification of NOD2 expression
by intracellular flow cytometry; gray filled histogram indicates isotype control,
red open histogram indicting specific staining. (G) Shows accumulation of
phosphorylated RIPK2 in cultured iSCs determined by flow cytometry after
stimulation for the indicated time periods with MDP. Data in (A) are
representative of tissue, (B–E) are from monocytes isolated from n=4
healthy peripheral blood donors and iSCs cultured from colonic tissue of n=8
uninflamed surgical patients. Data in (F,G) are from iSCs of one patient,
representative of four patients with similar results. **p<0.01, ***p<0.001.
(8), we initially sought to determine whether similar synergy
also existed in iSCs. Culture of iSCs with MDP alone induced
limited upregulation of IL1B mRNA expression (Figure 2A).
In contrast, triggering of TLR2 in iSCs with the TLR2 agonist
PAM3CSK4 resulted in an∼eightfold increase in IL1B expression.
Combined triggering of NOD2 and TLR2 significantly enhanced
expression of IL1B mRNA, to levels ∼24-fold higher than in
unstimulated cells, which was significantly higher than either
NOD2 or TLR2 triggering in isolation. This NOD2/TLR2 syn-
ergy in the activation of cytokine transcription was also extended
to several other IL-1 family members; with combined MDP and
PAM3CSK4 stimulation leading to significantly enhanced levels
of IL1A (p< 0.01 Figure 2B), IL18 (p< 0.01 Figure 2C) and
IL33 (p< 0.05 Figure 2D) mRNA expression than either ligand in
isolation. However this synergy was not extended to CSF2 (GM-
CSF; granulocyte-monocyte colony stimulating factor) expression,
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FIGURE 2 | Bacterial ligands regulate IL-1 family member cytokine
expression in iSCs. (A–F) Show changes in expression of the indicated
cytokines by cultured iSCs, (G) shows the same by monocyte-derived
dendritic cells (mDCs), determined by qRT-PCR after 24 h of in vitro
stimulation with the PRR ligands indicated. Data in (A–E) show mean
fold changes ±SEM in iSCs from colonic tissue of n=5 surgical
patients, (F) shows the mean induction of expression of the indicated
genes by iSCs from one patient after stimulation with flagellin,
representative of three experiments with similar results. (G) Shows
mean fold changes ±SEM in expression of the indicated mRNA in
stimulated mDCs generated from n=4 peripheral blood donors.
*p<0.05, **p<0.01, ***p<0.001.
where combined NOD2/TLR2 triggering regulated mRNA for
this cytokine at similar levels to TLR2 triggering in isolation
(Figure 2E).
As iSCs were found to express TLR5 at the mRNA level
(Figure 1B), we sought to determine the impact of stimula-
tion with the TLR5 ligand flagellin on cytokine transcription
(Figure 2F). Stimulation of iSCs with flagellin led to a dramatic
increase in mRNA encoding IL-1α, IL-1β, IL-18, IL-33, and GM-
CSF, with increases in expression of all cytokines ∼two to sixfold
higher than combined stimulation via NOD2/TLR2. When com-
pared directly to TLR/NLR ligand stimulated mDCs, iSCs showed
a more modest fold increase in IL1A and IL1B mRNA levels,
particularly apparent with dual MDP and PAM3CSK4 triggering,
although a similar fold increase in IL-33 mRNA transcription was
evident between the cell types (Figure 2G). Therefore iSCs can
respond to TLR2 and NOD2 ligands with a similar functional syn-
ergy to that seen in other immune cell types – including DCs – but
also respond strongly to stimulation with extracellular bacterial
flagellin.
RAPID INTERNALIZATION AND SENSING OF LIVE SALMONELLA BY iSCs
As the nature of iSC responses to isolated bacterial components
suggested a capacity for the sensing of intact bacteria by these
cells, we next assessed the ability of iSCs to respond to the
invasive mucosal pathogen Salmonella typhimurium (Figure 3).
We first compared the capacity for Salmonella to be taken up
by/invade iSCs, using as a reference point the well-defined capac-
ity for CD11chi peripheral blood monocyte-derived dendritic cells
(mDCs) to respond to in vitro infection with this pathogen. Using
both fluorescence microscopy and flow cytometry, the uptake of
GFP-expressing Salmonella by 2 h post-infection could be clearly
visualized for both iSCs and mDCs (Figure 3A). We verified the
immunofluorescence images using confocal microscopy, in order
to determine the presence of intracellular bacteria within iSCs
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FIGURE 3 | Rapid internalization and sensing of live Salmonella by iSCs.
(A) Shows presence of GFP+ Salmonella in CD11c+ mDCs and CD90+stromal
cells by representative fluorescence microscopy images (upper panels) and
flow cytometry plots (lower panels) after 2 h of bacterial exposure. (B) (upper
panel) shows the presence of GFP-expressing Salmonella in Vimentin+ iSCs
infected for 4 h at an MOI of 100; uninfected iSCs shown for comparison
(lower panel). (C) Shows quantification of Salmonella uptake/internalization by
mDCs and iSCs exposed to bacteria as in (A), expressed as the mean fold
change in GFP MFI determined by flow cytometry. (D–H) Show the mean fold
increases in expression of the indicated genes after exposure of iSCs to
Salmonella at an MOI of 10 for the indicated time periods, relative to
unstimulated cells. (A,B) shows representative images and FACS plots, data
in (C) quantified from mDCs generated from peripheral blood of n=3 healthy
donors, compared to iSCs from colonic tissue of n= 3 surgical patients. Data
in (D–H) are from iSCs isolated from colonic tissue of n= 3 patients.
*p<0.05, other p values as indicated.
(Figure 3B). GFP-expressing Salmonella were readily detectable
adjacent to Vimentin filaments within infected iSCs, determined
on stained 0.9µM slices that suggest bacterial internalization. Such
bacteria/GFP signals were entirely absent within uninfected iSCs.
When assessed by flow cytometry this bacterial internalization
was apparent at 4°C and enhanced at 37°C in mDCs, suggest-
ing a contribution of both invasion by the pathogen and active
uptake by the cell. Levels of internalization were comparable at
both temperatures for iSCs, suggesting that internalization was
primarily as a result of bacterial-mediated processes. When the
uptake of bacteria was quantified by flow cytometry as the fold
increase in GFP expression by viable CD11c+ or CD90+ cells,
mDCs were found to internalize Salmonella at a significantly
higher level than iSCs (80.78± 19.37 vs. 3.35± 0.56-fold increases
in GFP expression for mDCs vs. iSCs, p< 0.01 Figure 3C). There-
fore Salmonella rapidly accesses the intracellular compartment
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of iSCs although at a significantly lower rate than observed
with mDCs.
In light of the rapid Salmonella internalization in iSCs, we next
sought to determine the early transcriptional response to infec-
tion with intact bacteria. Focusing on the cytokines we found to be
induced in iSCs by isolated TLR ligands (Figure 2), we determined
the changes in expression of cytokine mRNA by iSCs after 60
and 120 min of exposure to live bacteria in vitro (Figures 3D–H).
IL1A expression was slightly enhanced by short-term infection,
although only increased over uninfected cells by ∼fourfold at
120 min (Figure 3D). In contrast the expression of IL1B and IL18
was more substantially increased, with significant fold changes in
expression of IL-1βmRNA (∼20-fold, p< 0.05) and IL-18 mRNA
(∼30-fold, p< 0.05) at 120 min post-infection (Figures 3E,F).
mRNA levels of both cytokines were also increased at 60 min post-
infection. IL33 expression showed a similarly modest change in
expression as IL1A, with levels of mRNA increasing by ∼fourfold
at 2 h post-infection (Figure 3G). The most dramatic changes in
cytokine gene expression were for CSF2, the gene encoding GM-
CSF, with levels increasing by up to 6000-fold at 2 h post-infection
(p< 0.05 Figure 3H). Taken together, these data suggest that iSCs
can respond rapidly to intracellular infection with Salmonella via
the transcriptional regulation of multiple IL-1 family cytokines
and GM-CSF.
SALMONELLA INFECTION STIMULATES IL-1β AND IL-33 PRODUCTION
BY iSCs
We next determined whether the rapid transcriptional responses
of iSCs to Salmonella were associated with corresponding increases
in cytokine production at the protein level (Figure 4). We exposed
iSCs to live or heat-killed Salmonella for 4 h, followed by treat-
ment of cells in all conditions with Gentamycin to kill extracel-
lular bacteria. After 24 h we assessed cell supernatants for lev-
els of iSC cytokine production by ELISA. TNFα was produced
constitutively by iSCs, and the levels of this cytokine were not
significantly altered by exposure to either heat-killed or live bac-
teria (Figure 4A). IL-33 was also detectable as a cytokine that was
constitutively produced by iSCs (Figure 4B). However in con-
trast to TNFα, the expression of IL-33 was significantly enhanced
upon infection specifically with live Salmonella. Exposure to live
bacteria significantly increased IL-33 production by iSCs, com-
pared with the response to heat-killed bacteria (224.74± 42.80
vs. 173.25± 32.24 pg/ml, p< 0.01). Exposure to heat-killed bac-
teria did not significantly modulate levels of iSC IL-33 pro-
duction from that in the absence of any contact with bacteria.
Production of IL-1β by iSCs was dramatically modulated after
contact with live Salmonella (Figure 4C). This was reflected by
an almost 10-fold increase in IL-1β protein production, from
256.84± 148.22 pg/ml by iSCs when exposed to heat-killed bac-
teria to 2522.91± 2051 pg/ml (p< 0.01) when iSCs were infected
with live Salmonella. Similar to the results with IL-33, exposure of
iSCs to heat-killed bacteria did not increase IL-1β production over
the levels observed when iSCs remained unstimulated. Thus iSCs
elaborate IL-1β and IL-33 protein in response to infection with
live Salmonella.
iSC RESPONSES TO SALMONELLA REQUIRE RIPK2/p38MAPK
SIGNALING
We next sought to investigate the signaling pathways involved in
iSC sensing of Salmonella. We used the selective RIPK2/p38MAPK
inhibitor SB203580 to inhibit signaling pathways downstream of
NOD2 (8) (and other PRRs) (Figure 5). Enhanced transcription
of IL1B in response to Salmonella was robustly observed across
stromal cells from six individual patients and averaged an ∼10-
fold increase over uninfected cells after 6 h of infection (p< 0.05).
Treatment of iSCs with DMSO alongside Salmonella infection
had no significant impact on the fold increases in IL1B mRNA
expression by iSCs. However, treatment with SB203580 completely
abrogated the Salmonella-induced increase in IL1B expression
(p< 0.05), with an mRNA level indistinguishable from uninfected
FIGURE 4 | Salmonella infection stimulates IL-1β and IL-33
production by iSCs. (A–C) show production levels of the indicated
cytokines over a 24 h period by iSCs, determined by ELISA. iSCs
were left unstimulated (−) or exposed to live or heat-killed
Salmonella at an MOI of 10 for 4 h, followed by addition of
Gentamycin for the subsequent 20 h. Data are mean levels of
cytokine produced by iSCs isolated from colonic tissue of n=8
surgical patients. **p<0.01.
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FIGURE 5 | Intestinal stromal cell responses to Salmonella require
RIPK2/p38MAPK signaling. Figure 5 shows relative fold changes in IL1B
expression determined by qRT-PCR in iSCs left uninfected or after 6 h of
infection with live Salmonella at an MOI of 10, in the presence of bacteria
alone (−), DMSO or SB203580. Data show mean±SEM fold increases in
IL1B expression by iSCs under the indicated conditions isolated from n=6
surgical patients. *p<0.05.
cells. Thus iSCs require RIPK2/p38MAPK signaling in order to
facilitate transcriptional responses to Salmonella infection.
iSCs HAVE A LIMITED CAPACITY FOR PHAGOCYTOSIS AND ANTIGEN
PROCESSING
In light of the capacity for iSCs to sense infection with live bacte-
ria presented above, and in addition their reported expression of
HLA-DR (13), we next compared whether iSCs had the capac-
ity to perform functions typically associated with professional
innate immune cells/APCs (Figure 6). First we assessed the phago-
cytic potential of iSCs, again comparing them to CD11chi mDCs
(Figure 6A). After pulsing cells for 4 h at 4°C or 37°C with FITC-
labeled latex beads, we determined the phagocytic capacity of
mDCs vs. iSCs by assessing the frequencies of FITC positive cells
by flow cytometry. At 4°C, mDCs and iSCs showed very low levels
of bead uptake that provided the baseline for the assay, with the
higher FITC MFI of iSCs a result of the autofluorescent nature
of these cells. Pulsing of mDCs at 37°C led to a dramatic uptake
of beads by these cells, reflected in an ∼10-fold increase in FITC
MFI over background levels. This was in comparison to a signifi-
cantly lower but still present bead uptake by iSCs, at approximately
threefold over cells at 4°C (p< 0.05).
We next determined the capacity for iSCs to process antigen.
Using FITC expression as a readout, we pulsed mDCs and iSCs
for 4 h with DQ-OVA, a fluorescently tagged model antigen with
emission quenched until antigen is processed (Figure 6B). Again
levels of processing were low in both cell types at 4°C, with no
processing detectable at this temperature. At 37°C, the antigen-
processing capacity of mDCs and iSCs was strikingly different;
mDCs processed antigen efficiently, reflected in an ∼300-fold
increase in FITC MFI whereas iSCs were only capable of process-
ing antigen to give an ∼fivefold increase in MFI 4 h after pulsing
(p< 0.001). Taken together, these data revealed that iSCs have a
significantly impaired capacity for both phagocytosis and antigen
processing when compared to professional APCs, yet neverthe-
less retain a limited ability to perform these prototypical innate
immune functions.
DISCUSSION
In this study we show that human iSCs exhibit an array of innate
immune functions. Previous studies in the human system had
focused mainly on the CCD18co colonic myofibroblastic cell line,
and the functional responses upon stromal bacterial challenge
were limited to IL-8 expression (3). We have built on these obser-
vations with experiments exclusively in primary human colonic
stromal cells, and could confirm much of the reported data relat-
ing to expression of NOD1, NOD2, and multiple TLRs at the
mRNA level. We also provide evidence that broadens the potential
range of PRRs expressed by iSCs to include components of the
NLR family signaling pathway, including NLRP1, NLRP3, and the
inflammasome adaptor PYCARD.
Our functional data validates observations in murine stromal
cells that suggested NOD2 signaling could occur in response to
Citrobacter rodentium infection (4), and reveals for the first time
than human iSCs express NOD2 at the protein level and function-
ally respond with phosphorylation of the signaling intermediate
RIPK2 after stimulation with the NOD2 ligand MDP. We found
that stimulation with a NOD2 ligand regulated the expression of
multiple members of the IL-1 family of cytokines, with NOD2
triggering synergizing with TLR2 stimulation to increase the mag-
nitude of transcriptional responses, a process seemingly conserved
between iSCs and myeloid cells (14).
Similar NOD2-dependent innate immune functions in stro-
mal cells have been reported in the human system previously.
NOD2 expression is detectable at the mRNA level in oral stro-
mal cells, and MDP stimulation in vitro regulates IL-6, IL-8, and
CCL2 production by these cells (15). In contrast to the expres-
sion of NOD2 mRNA we found in steady-state intestinal SCs,
oral stromal cell expression of NOD2 mRNA is dependent on
inflammatory cytokines, suggesting differences in basal NOD2
expression by stromal cells dependent on tissue localization. It
will be interesting to determine whether there are differences in
NLR/PRR expression in stromal cells isolated from distinct regions
of the intestinal mucosa, e.g., Ileum vs. Colon, that may contribute
to or be affected by the differing bacterial composition at these
sites, and the distinct inflammatory lesions that can occur at these
anatomical positions during disease.
Similar to stromal cells of the oral mucosa, no basal expression
of NOD2 is detectable in Rheumatoid Arthritis Synovial Fibrob-
lasts (RASFs), with NOD2 mRNA expression in these stromal
populations only detectable after stimulation with POLYI:C, LPS,
or TNFα (16). Interestingly, a similar synergy between NOD2 and
TLR2 signaling is observed in cells from this site, whereby co-
triggering with ligands of these PRRs synergistically enhances the
expression of IL-6 and IL-8 via a p38MAPK-dependent mecha-
nism (16). Synergy in multiple PRR signaling pathways has also
been reported (17), and it has been suggested that such synergy
may be specific to the TLR2 and NOD2 signaling pathways in
stromal cells isolated from the oral mucosa (18, 19). A major out-
standing question is whether the signaling pathways underlying
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FIGURE 6 | Intestinal stromal cells have a limited capacity for
phagocytosis and antigen processing. (A) shows the quantification of
FITC-labeled bead uptake by CD11c+ mDCs or CD90+ cultured iSCs,
determined by flow cytometry at either 4°C (blue filled histograms) or
37°C (red open histograms), expressed as the fold increase in FITC MFI
expression by cells at 37°C vs. 4oC. (B) Shows quantification of antigen
processing by CD11c+ mDCs or CD90+ iSCs, determined by flow
cytometry after pulsing with DQ-OVA at either 4°C (blue filled histograms)
or 37°C (red open histograms), expressed as the fold increase in FITC MFI
expression by cells at 37°C vs. 4°C. Data in (A,B) show mean fold
increases in FITC MFI by mDCs and iSCs from n= 3–5 patients. P values
as indicated.
the synergy between simultaneous NOD2 and TLR2 triggering
are conserved between myeloid and stromal cells or whether cell
type-specific pathways result in broadly similar transcriptional and
functional outcomes.
We found NOD1 to be highly expressed in iSCs, and indeed
this receptor was the only PRR expressed in iSCs at similar lev-
els to monocytes. NOD1 is also strongly expressed in synovial
stromal cells and may have a dominant role over NOD2 at this
site (20). It is possible that the expression of NOD1 is not as
tightly regulated as that of NOD2, reflected in the higher levels of
basal expression in stromal cells, further work will be required to
address this. Given the role of both NOD1 and NOD2 in direct-
ing autophagy as an innate immune strategy in myeloid cells (8,
21), and recent data indicating that human iSCs exhibit similar
ATG16L1-dependent autophagosome formation in some contexts
(22), it will be interesting to determine whether NOD1 and/or
NOD2 can direct autophagy induction as a component of innate
defense in the intestinal stromal compartment, in addition to in
myeloid cells.
In addition to the responses we observed with NOD2 and TLR2
ligands, we found that iSCs exhibited a particularly strong response
to stimulation with extracellular flagellin. Given that extracellular
flagellin fails to activate IPAF (NLRC4) in myeloid cells (23) and
indeed we found that human iSCs do not express detectable lev-
els of NLRC4 mRNA, it is unlikely that this NLR mediates the
responses we observed. It is thus feasible that flagellin signals via
TLR5, which we found expressed by iSCs at the mRNA level, and
is also expressed at the basolateral surface of IECs (24). As the
basolateral surface of IECs interfaces anatomically with a layer of
iSCs in the gut (1), it is likely that both IEC and iSC TLR5 signal-
ing would contribute to the sensing of invasive bacteria that access
the subepithelial compartment of the intestine. However, the pro-
duction of IL-1β by iSCs in response to contact with live, but not
heat-killed, Salmonella suggests that there may be a requirement
for cytosolic sensing of flagellin that may be delivered either by
bacterial internalization, which we confirmed was occurring in
these cells using confocal microscopy, or via a type III secretion
system only operating on a live bacterium. Further work will be
required to address this.
In addition to characterizing their innate sensing capacity, we
sought to clarify the potential role of iSCs as antigen present-
ing cells. Previous data indicated that iSCs can express HLA-DR
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(25), and that this expression is robustly induced in response to
IFNγ (13). Previous work had also showed presentation of anti-
gen to a T cell clone following transfection of a specific HLA
molecule into the CCD18co cell line, in addition to the capac-
ity for freshly isolated iSCs to induce HLA-DR-dependent IL-2
production by CD4+ T cells (13), as well as allowing for SEB-
mediated CD4+ T cell responses (26). Here we addressed the direct
antigen-processing capacity of steady-state iSCs, which indicated
that although they have some capacity to process soluble antigen,
this function was inferior to that observed in professional APCs.
It would be interesting to determine whether this deficit would be
less pronounced in iSCs isolated from patients with active inflam-
mation, or by iSCs after stimulation in vitro with inflammatory
cytokines. It is possible that the lower levels of antigen-processing
capacity observed in iSCs may be related to their tolerogenic capac-
ity, as previously indicated by the HLA-DR-dependent induction
of regulatory T cells (27) and the functional regulation of CD4+
T cell phenotype by iSCs via PD-L1 expression (10). Lymphoid
organ stromal cells can mediate T cell tolerance (28), via the pre-
sentation of peripheral tissue antigens (29), and can also regulate
T cell proliferation via production of nitric oxide (30), although it
is not yet clear if similar mechanisms operate in iSCs.
Stromal cells in the gut have a major role in wound heal-
ing and epithelial regeneration (31), so in addition to producing
chemokines (4) and cytokines in response to bacterial challenge, it
is possible that a range of epithelial healing/repair factors are also
regulated upon sensing of invasive bacteria. We found that expres-
sion of IL-33 was rapidly induced at both the mRNA and protein
level upon infection of iSCs with Salmonella, and IL-33 may itself
be a candidate for a mucosal healing or repair factor,given its role as
a major mediator of epithelial regeneration and homeostasis in the
gut (32). Interestingly, colonic stromal cells have been reported as
major producers of IL-33 during active intestinal inflammation in
humans (33) and it is thus possible this enhanced expression may
be at least in part a result of the sensing of bacterial translocation
by stromal cells at the mucosa during active disease.
An interesting future question is to address whether subsets of
iSCs exist in vivo with distinct innate immune potential. Previous
work has identified massive heterogeneity even within stromal cells
isolated from a single human organ (34), and as iSCs have distinct
localization and positioning (2), it is feasible that certain iSC sub-
sets are equipped with innate immune functional specialization.
Although not yet defined, there is likely to be considerable pheno-
typic and functional heterogeneity within the iSC compartment,
as suggested by recent data characterizing the stromal cell popu-
lations of lymph nodes (35, 36). Interestingly, the innate immune
capacity of stromal cells appears to be evolutionarily conserved,
as stromal cells of teleost fish can act as sentinels and thus sense
infection and inflammation (37).
In summary we have shown that human iSCs are able to exhibit
multiple innate immune functions, albeit with some of these
at significantly limited levels compared with professional innate
immune cells. Stromal cells are likely to be important in innate
immune responses to invasive pathogens, e.g., invasive Salmo-
nella, however it is likely that the epithelium plays a dominant
role in innate immunity in the steady-state (38). Nevertheless,
after a breach or damage to the contiguous epithelium, or indeed
following active invasion by bacteria, stromal cells are perfectly
positioned to respond with multiple effector pathways to initi-
ate, coordinate, and focus a professional innate immune response,
allowing for both effective defense of the host and for the mucosal
barrier to regain homeostasis.
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